NIVAGEN PHARMS INC
GenericsNIVAGEN PHARMS INC is a generic drug manufacturer focused on Oncology.
NIVAGEN PHARMS INC's Key Drugs
NIVAGEN PHARMS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
NIVAGEN PHARMS INC's Recent FDA Approvals
New NDA/BLA approvals for NIVAGEN PHARMS INC over the last two years — novel drugs only, excluding generics and label supplements.
NIVAGEN PHARMS INC's Therapeutic Areas
NIVAGEN PHARMS INC's approved drugs and pipeline span 1 therapeutic area, led by Oncology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
NIVAGEN PHARMS INC's Top Competitors
NIVAGEN PHARMS INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
NIVAGEN PHARMS INC Pipeline Snapshot
Active clinical trials for NIVAGEN PHARMS INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2020-05-19
- Latest
- 2024-10-11
- Applications
- 9